<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>cancer staging &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/cancer-staging/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Mon, 05 Oct 2026 14:25:35 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.2</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>cancer staging &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>When the Sentinel Node Vanishes: Hidden Warning Sign in Head and Neck Melanoma</title>
		<link>https://bioengineer.org/when-the-sentinel-node-vanishes-hidden-warning-sign-in-head-and-neck-melanoma/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Mon, 05 Oct 2026 14:25:35 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[cancer staging]]></category>
		<category><![CDATA[Head and neck cancer]]></category>
		<category><![CDATA[lymphatic mapping]]></category>
		<category><![CDATA[lymphoscintigraphy]]></category>
		<category><![CDATA[melanoma]]></category>
		<category><![CDATA[melanoma recurrence]]></category>
		<category><![CDATA[nuclear medicine]]></category>
		<category><![CDATA[retrospective cohort study]]></category>
		<category><![CDATA[sentinel lymph node biopsy]]></category>
		<category><![CDATA[SPECT/CT]]></category>
		<category><![CDATA[Surgical Oncology]]></category>
		<category><![CDATA[tumour ulceration]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=402679</guid>

					<description><![CDATA[A seventeen-year study of 400 patients finds that failure to visualise the sentinel lymph node on preoperative imaging in head and neck melanoma affects nearly one in eleven patients and is associated with a recurrence rate of 31.4 percent.]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">402679</post-id>	</item>
		<item>
		<title>Spectral CT Muscle and Tissue Measures Predict Survival After Junctional Cancer Surgery</title>
		<link>https://bioengineer.org/spectral-ct-muscle-and-tissue-measures-predict-survival-after-junctional-cancer-surgery/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Mon, 05 Oct 2026 13:10:45 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[body composition]]></category>
		<category><![CDATA[cancer staging]]></category>
		<category><![CDATA[CEA]]></category>
		<category><![CDATA[Cox regression]]></category>
		<category><![CDATA[disease-free survival]]></category>
		<category><![CDATA[esophagogastric junction adenocarcinoma]]></category>
		<category><![CDATA[extracellular volume fraction]]></category>
		<category><![CDATA[Medical Imaging]]></category>
		<category><![CDATA[prognosis]]></category>
		<category><![CDATA[sarcopenia]]></category>
		<category><![CDATA[skeletal muscle index]]></category>
		<category><![CDATA[spectral CT]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=402523</guid>

					<description><![CDATA[A new study shows that combining spectral CT-derived extracellular volume and skeletal muscle index with CEA and tumor stage improves preoperative prediction of disease-free survival after surgery for adenocarcinoma of the esophagogastric junction.]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">402523</post-id>	</item>
		<item>
		<title>Radiologists Sound the Alarm on the World Standard for Staging Childhood Liver Cancer</title>
		<link>https://bioengineer.org/radiologists-sound-the-alarm-on-the-world-standard-for-staging-childhood-liver-cancer/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Mon, 05 Oct 2026 12:42:53 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[cancer staging]]></category>
		<category><![CDATA[hepatoblastoma]]></category>
		<category><![CDATA[inter-observer variability]]></category>
		<category><![CDATA[liver transplantation]]></category>
		<category><![CDATA[MRI]]></category>
		<category><![CDATA[pediatric liver tumors]]></category>
		<category><![CDATA[POSTTEXT]]></category>
		<category><![CDATA[PRETEXT]]></category>
		<category><![CDATA[radiology]]></category>
		<category><![CDATA[risk stratification]]></category>
		<category><![CDATA[SIOPEL]]></category>
		<category><![CDATA[structured reporting]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=402463</guid>

					<description><![CDATA[A new SIOPEL Radiology Group position paper details how variability in imaging, ambiguous definitions, and surgical mismatches challenge the PRETEXT staging system used worldwide for children with malignant liver tumors.]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">402463</post-id>	</item>
	</channel>
</rss>
